Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited
- PMID: 10433145
- DOI: 10.1080/110241599750006514
Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited
Abstract
Objective: To assess whether Jass staging enhances prognostic prediction in Dukes' B colorectal carcinoma.
Design: A historical cohort observational study.
Setting: A university tertiary care centre, Switzerland.
Subjects: 108 consecutive patients.
Interventions: Curative resection of Dukes' B colorectal carcinoma between January 1985 and December 1988, Patients with familial adenomatous polyposis; hereditary non-polyposis colorectal cancer; Crohns' disease; ulcerative colitis and synchronous and recurrent tumours were excluded. A comparable group of 155 consecutive patients with Dukes' C carcinoma were included for reference purposes.
Main outcome measures: Disease free and overall survival for Dukes' B and overall survival for Dukes' C tumours.
Results: Dukes' B tumours in Jass group III or with an infiltrated margin had a significantly worse disease-free survival (p = 0.001 and 0.0001, respectively) and those with infiltrated margins had a significantly worse overall survival (p = 0.002). Overall survival among those with Dukes' B Jass III and Dukes' B with infiltrated margins was no better than overall survival among all patients with Dukes' C tumours.
Conclusion: Jass staging and the nature of the margin of invasion allow patients undergoing curative surgery for Dukes' B colorectal carcinoma to be separated into prognostic groups. A group of patients with Dukes' B tumours whose prognosis is inseparable from those with Dukes' C tumours can be identified, the nature of the margin of invasion being used to classify a larger number of patients.
Similar articles
-
For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.Cancer. 1998 Aug 15;83(4):666-72. Cancer. 1998. PMID: 9708929
-
A Dukes/Jass combination--is it more discriminating?Colorectal Dis. 2006 Jun;8(5):418-22. doi: 10.1111/j.1463-1318.2006.00957.x. Colorectal Dis. 2006. PMID: 16684086
-
Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.Oncol Rep. 2003 Jul-Aug;10(4):927-34. Oncol Rep. 2003. PMID: 12792747
-
Adjuvant chemotherapy for colorectal cancer.Ann R Coll Surg Engl. 1995 Mar;77(2):81-4. Ann R Coll Surg Engl. 1995. PMID: 7793820 Free PMC article. Review.
-
Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma.Ann Thorac Surg. 2004 Jul;78(1):238-44. doi: 10.1016/j.athoracsur.2004.02.017. Ann Thorac Surg. 2004. PMID: 15223436 Review.
Cited by
-
Peritumoral inflammatory infiltrate is not a prognostic factor in distal rectal cancer following neoadjuvant chemoradiation therapy.J Gastrointest Surg. 2007 Nov;11(11):1534-40. doi: 10.1007/s11605-007-0287-8. Epub 2007 Sep 1. J Gastrointest Surg. 2007. PMID: 17786526
-
Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect--a histopathological and immunohistochemical study.BMC Cancer. 2001;1:7. doi: 10.1186/1471-2407-1-7. Epub 2001 Jul 16. BMC Cancer. 2001. PMID: 11481031 Free PMC article.
-
Association between histological type of tumour growth and patient survival in t2-t3 lymph node-negative rectal cancer treated with sphincter-preserving total mesorectal excision.Pathol Oncol Res. 2010 Jun;16(2):201-6. doi: 10.1007/s12253-009-9207-4. Epub 2009 Sep 15. Pathol Oncol Res. 2010. PMID: 19757194 Clinical Trial.
-
The role of hypoxia in recurrence following resection of Dukes' B colorectal cancer.Int J Colorectal Dis. 2008 Nov;23(11):1049-55. doi: 10.1007/s00384-008-0497-x. Epub 2008 Jul 2. Int J Colorectal Dis. 2008. PMID: 18594846
Publication types
MeSH terms
LinkOut - more resources
Medical